Are quinolone-resistant uropathogenic Escherichia coli less virulent?

被引:147
作者
Vila, J
Simon, K
Ruiz, J
Horcajada, JP
Velasco, M
Barranco, M
Moreno, A
Mensa, J
机构
[1] Univ Barcelona, Fac Med, Hosp Clin, IDIBAPS,Inst Clin Infecc & Immunol,Serv Microbiol, Barcelona 08036, Spain
[2] Univ Barcelona, Fac Med, Hosp Clin, IDIBAPS,Inst Clin Infecc & Immunol,Serv Malalties, Barcelona 08036, Spain
关键词
D O I
10.1086/342955
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The prevalence of hemolysin, type 1 fimbriae, P fimbriae, cytotoxic necrotizing factor-1 (CNF-1), aerobactin, and autotransporter toxin (sat) was analyzed by polymerase chain reaction and phenotypic assays of 42 epidemiologically unrelated Escherichia coli strains causing acute pyelonephritis in women (21 nalidixic acid-susceptible and 21 nalidixic acid-resistant strains) and 58 E. coli strains causing cystitis in women (29 nalidixic acid-susceptible and 29 nalidixic acid-resistant strains). Hemolysin and CNF-1 were less prevalent (P < .05) in nalidixic acid-resistant than in nalidixic acid-susceptible E. coli strains from patients with either pyelonephritis (14.3% vs. 52.4%) or cystitis (0% vs. 31.0%). Among E. coli strains causing cystitis, type 1 fimbriae expression was less prevalent (P < .05) in the nalidixic acid-resistant group (55.2%) than in the nalidixic acid-susceptible group (86.2%). None of the nalidixic acid-resistant and 20.7% of the nalidixic acid-susceptible strains causing cystitis showed the proteolytic toxin Sat (P < .05). These results suggest that resistance to quinolones may be associated with a decrease in the presence or the expression of some virulence factors in uropathogenic E. coli.
引用
收藏
页码:1039 / 1042
页数:4
相关论文
共 15 条
[1]   Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli [J].
Bagel, S ;
Hüllen, V ;
Wiedemann, B ;
Heisig, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :868-875
[2]  
BAGEL S, 1997, 37 INT C ANT AG CHEM, P52
[3]   Identification of Sat, an autotransporter toxin produced by uropathogenic Escherichia coli [J].
Guyer, DM ;
Henderson, IR ;
Nataro, JP ;
Mobley, HLT .
MOLECULAR MICROBIOLOGY, 2000, 38 (01) :53-66
[4]   Pathogenicity islands of virulent bacteria: Structure, function and impact on microbial evolution [J].
Hacker, J ;
BlumOehler, G ;
Muhldorfer, I ;
Tschape, H .
MOLECULAR MICROBIOLOGY, 1997, 23 (06) :1089-1097
[5]   Diagnosis and treatment of uncomplicated urinary tract infection [J].
Hooton, TM ;
Stamm, WE .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (03) :551-+
[6]   VIRULENCE FACTORS IN ESCHERICHIA-COLI URINARY-TRACT INFECTION [J].
JOHNSON, JR .
CLINICAL MICROBIOLOGY REVIEWS, 1991, 4 (01) :80-128
[7]   AEROBACTIN AND OTHER VIRULENCE FACTOR GENES AMONG STRAINS OF ESCHERICHIA-COLI CAUSING UROSEPSIS - ASSOCIATION WITH PATIENT CHARACTERISTICS [J].
JOHNSON, JR ;
MOSELEY, SL ;
ROBERTS, PL ;
STAMM, WE .
INFECTION AND IMMUNITY, 1988, 56 (02) :405-412
[8]  
KORHONEN TK, 1979, FEMS MICROBIOL LETT, V6, P421, DOI 10.1016/0378-1097(79)90148-4
[9]   Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli [J].
Martínez-Martínez, L ;
Fernández, F ;
Perea, EJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) :277-279
[10]  
PEREZTRALLERO E, 1993, EUR J CLIN MICROBIOL, V12, P349